Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/85334
Author(s): Antonio Araújo
Title: Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK-Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls.
Issue Date: 2016-09
URI: https://repositorio-aberto.up.pt/handle/10216/85334
Document Type: Artigo em Revista Científica Internacional
Rights: openAccess
License: https://creativecommons.org/licenses/by-nc/4.0/
Appears in Collections:ICBAS - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
143041.pdf474.64 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons